Triflusal

三氟柳

Report date: 2022/01/17 12:14:22
NME

Base Information

Drug NameTriflusal
Drug Alias Name三氟醋铆酸Aflen三氟醋柳酸DisgrenTriflux +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet aggregation inhibitorsThromboxane A2 synthase inhibitors
TargetsNot applicable
Therapy Area/IndicationsInsulin ResistanceBlood Platelet DisordersThrombosis +[5] 
Global Approved IndicationsThrombosisThromboembolism
Approved Indications in ChinaN/A
Original Approved Country/TerritorySpain
Original Approved Date1981/01/01
Country/TerritorySpainMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesUriach
China Registration ClassN/A

Develop Information

Active CompaniesUriachFuren Pharmaceutical Group Co LtdXi'an Xintong Pharmaceutical Research Co Ltd +[4] 
Inactive CompaniesJ. Uriach & Co
Active IndicationsBlood Platelet DisordersThrombosisThromboembolism +[4] 
Inactive IndicationsInsulin Resistance

Other Information

ATC CodeB01AC18
Related LinksWikipediaDrugBankKEGG